Meet our Leadership Team

Our diversity of skills and the collective experience of the team at Glycotope are what make us strong

The contribution of each individual employee is valued to constantly develop and improve our approach. We believe in supportive cooperation at every level of our company, as well as with our partners, to achieve our common goals.

Henner Kollenberg

CEO

Henner serves as CEO since 2017 prior to holding executive functions at Glycotope since 2014. He has more than 20 years of experience in management functions including strategy, finance, operations and venture capital.

Antje Danielczyk

COO

Antje is responsible for the Research & Development operations. She is a biochemist specialized in the development of recombinant antibody-based therapeutics.

Patrik Kehler

CSO

Patrik heads the Research & Development department. He is an immunologist specialized in the development of therapeutics in the field of oncology.  

Johanna Gellert

Head of Program Management

Johanna is an experienced biologist with 15+ years experience in developing pre-clinical drug leads in the field of oncology.

Stephanie Gurka

Interim Lead of Platform Development

Stephanie leads the Platform Development group on an interim basis. She is an immunologist with experience in preclinical development of anti-tumor vaccines, cell line development and recombinant protein expression and characterization.

Jenny Schewe

Head of Finance & Controlling

Jenny serves as Head of Finance and Controlling since 2017. She has more than 12 years of experience in finance and controlling functions.

Sebastian Bloszyk

Legal Counsel

Sebastian serves as Legal Counsel at Glycotope.  He is a business lawyer specialized in the fields of contract and company law.

Stella Homann

Human Ressources Manager

Stella joined Glycotope in 2012.
She holds a degree from Freie Universit├Ąt Berlin
with specialization in HR